PRX-112

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	2

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02107846 (ClinicalTrials.gov)	April 2014	4/4/2014	An Open-Label, Dose Escalation Study to Evaluate the Safety and the Pharmacokinetics of Oral PRX-112 ...	A Phase 2a, Open-Label, Sequential Dose Escalation Study to Evaluate the Safety and the Pharmacokine ...	Gaucher Disease	Drug: PRX-112	Protalix	NULL	Completed	18 Years	N/A	Both	10	Phase 2	Israel
2	NCT01747980 (ClinicalTrials.gov)	March 2013	5/12/2012	Safety and Pharmacokinetics of Oral PRX-112 in Gaucher Disease Patients	An Exploratory, Open-label Study to Evaluate the Safety of PRX-112and Pharmacokinetics of Oral prGCD ...	Gaucher Disease	Drug: PRX-112	Protalix	NULL	Completed	18 Years	N/A	Both	16	Phase 1	Israel

First Previous1Next Last